Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
Trending News
More News >
News
Enterprise Solutions
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Calculators
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
TNYA
Stock Latest News
Ratings
Promising Outlook for Tenaya Therapeutics: Buy Rating Backed by Strategic Advantages and Market Opportunities
5d ago
TNYA
Premium
Ratings
Promising Phase 1b/2 Results for Tenaya’s TN-201 Support Buy Rating
19d ago
TNYA
Premium
Ratings
Buy Rating Affirmed for Tenaya Therapeutics Amid Promising TN-201 Data and Financial Stability
19d ago
TNYA
Premium
Ratings
Promising Clinical Trial Results for TN-201 Support Buy Rating for Tenaya Therapeutics
20d ago
TNYA
Premium
Ratings
Promising Developments and Expert Endorsements Bolster Buy Rating for Tenaya Therapeutics
20d ago
TNYA
Premium
The Fly
Tenaya data further builds TN-201 profile, says H.C. Wainwright
20d ago
TNYA
Premium
Ratings
Promising Developments in Tenaya Therapeutics’ Gene Therapy Trials Bolster Buy Rating
20d ago
TNYA
Premium
The Fly
Tenaya says TN-201 well tolerated in Phase 1b/2 interim data
20d ago
TNYA
Premium
Ratings
Promising Developments in Tenaya Therapeutics’ TN-201 Program Justify Buy Rating
26d ago
TNYA
Premium
The Fly
Tenaya Therapeutics publishes preclinical data on TN-201 in cardiac function
27d ago
TNYA
Premium
The Fly
Tenaya Therapeutics files $300M mixed securities shelf
1M ago
TNYA
Premium
Ratings
Tenaya Therapeutics: Strong Financial Position and Promising Clinical Trial Results Justify Buy Rating
1M ago
TNYA
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
PFE
ALGS
Premium
Ratings
Promising Clinical Data and Financial Stability Support Buy Rating for Tenaya Therapeutics Despite Price Target Reduction
1M ago
TNYA
Premium
The Fly
Tenaya Therapeutics price target lowered to $6 from $18 at Canaccord
1M ago
TNYA
Premium
Ratings
Buy Rating for Tenaya Therapeutics: Strong Clinical Progress and Financial Stability
1M ago
TNYA
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
AEON
APRE
Premium
The Fly
Tenaya Therapeutics price target lowered to $5 from $15 at Morgan Stanley
1M ago
TNYA
Premium
Company Announcements
Tenaya Therapeutics Advances Gene Therapy Pipeline
1M ago
TNYA
Premium
The Fly
Tenaya Therapeutics price target lowered to $9 from $18 at Chardan
1M ago
TNYA
Premium
The Fly
Tenaya Therapeutics price target lowered to $5 from $18 at H.C. Wainwright
1M ago
TNYA
Premium
Ratings
Promising Clinical Developments and Strategic Advancements Support Buy Rating for Tenaya Therapeutics
1M ago
TNYA
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
